A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom

ConclusionThe higher injection frequency in the T&E cohort may account for the trend toward improved vision.FundingNovartis Pharma AG, Basel, Switzerland

Source: Advances in Therapy - January 30, 2017 Category: Drugs & Pharmacology Source Type: research